Folium Biosciences Colorado: Stock hiking, cutting corners, sidestepping regulatory requirements & strong arm tactics

Folium Biosciences, based in Colorado, is one of the US’s largest privately owned CBD processing companies. As the demand for CBD has risen from many sectors of the US & international economy over the last 36 months, so, it seems, has the desire to process business without the normal checks and balances. After a CLR story published last month about owner , Kashif Shan, further irregularities and questions about Folium’s products and operational management have come to light. CannTrust was a wake up for the regulated Canadian market will Folium be the same  for the USA as 2019 draws to a close. Colorado has long been regarded one of the the US’s better state markets for efficient compliance and good regulatory management by state and local authorities. We ask, after the following revelations detailed below, if in the first 2020 sitting, CO legislators have to go back to the drawing board and effect a stricter regulatory and compliance regime than the state currently has in play. Teri Buhl reports   PART I Formulating Folium Finance: Australis Stock Hiked after Misleading Folium Announcement   Colorado based Folium Biosciences, run by Kashif Shan, teamed up with Scott Dowty of publicly traded Australis ($AUSAF),…

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : Folium Biosciences Colorado: Stock hiking, cutting corners, sidestepping regulatory requirements & strong arm tactics
reposted by Cannabis News World